Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Change in Acquisitions & Divestments (2022 - 2025)

Oramed Pharmaceuticals' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $17.4 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $17.4 million; the TTM value through Dec 2025 reached $40.3 million, changed N/A, while the annual FY2025 figure was $54.4 million, 15.58% down from the prior year.
  • Change in Acquisitions & Divestments reached $17.4 million in Q4 2025 per ORMP's latest filing, up from $877000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $116.0 million in Q2 2022 to a low of -$115.7 million in Q3 2022.
  • Average Change in Acquisitions & Divestments over 4 years is $5.2 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 98.94% in 2023, then surged 1527.34% in 2024.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $1.5 million in 2022, then increased by 4.84% to $1.6 million in 2023, then grew by 23.08% to $2.0 million in 2024, then skyrocketed by 772.5% to $17.4 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Change in Acquisitions & Divestments are $17.4 million (Q4 2025), $877000.0 (Q1 2025), and $2.0 million (Q3 2024).